Skip to main content

Javier Hernandez Losa

Institutions of which they are part

Main researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Javier Hernandez Losa

Institutions of which they are part

Main researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Projects

Red Temática de Investigación Cooperativa en Cáncer (RTICC)

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Cleofé Romagosa Pérez-Portabell, Maria Rosa Somoza Lopez de Haro, Meritxell Bellet Ezquerra, Cristina Saura Manich, Angel García Jiménez, Patricia Gómez Pardo, Roso Marès Pagès, Teresa Moline Marimon, Josep Castellví Vives, Judith Balmaña Gelpí, Pere Barba Suñol, Eva Muñoz Couselo, Javier Hernandez Losa, Marta Sese Faustino, Vicente Peg Camara, Stefania Landolfi , Trond Aasen
Funding agency: Instituto de Salud Carlos III
Funding: 209700
Reference: RD12/0036/0057
Duration: 01/01/2013 - 30/06/2017

Validación de Aprataxina como biomarcador de respuesta a Irinotecan en pacientes con cáncer colorrectal (ERANET- TRANSCAN)

IP: -
Collaborators: Javier Hernandez Losa, Stefania Landolfi , Elena Andretta
Funding agency: Instituto de Salud Carlos III
Funding: 135883
Reference: PI12/03103 (TRANSCAN)
Duration: 01/01/2013 - 30/06/2017

Identificación de nuevas dianas para el tratamiento del cáncer basada en el estudio de factores cap-independientes activados en tumores malignos

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Maria Rosa Somoza Lopez de Haro, Teresa Moline Marimon, Josep Castellví Vives, Maria Teresa Salcedo Allende, Javier Hernandez Losa, Vicente Peg Camara, Trond Aasen
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 9283
Reference: FMM-2011-11
Duration: 01/09/2011 - 31/08/2012

Estudio de factores moleculares y vías de señalización asociados a resistencia/sensibilidad al tratamiento con Irvalec

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Maria Rosa Somoza Lopez de Haro, Javier Hernandez Losa
Funding agency: CENTRO PARA EL DESARROLLO TÉCNICO INDUSTRIAL (CDTI
Funding: 356298.75
Reference: CENIT-2009-01
Duration: 15/09/2009 - 31/12/2012

Related news

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

Related professionals

Anna Belen Canovas Segura

Anna Belen Canovas Segura

Research technician
Peripheral Nervous System
Read more
Javier Pérez Garreta

Javier Pérez Garreta

Predoctoral researcher
Microbiology
Read more
Francisco Torralba Saban

Francisco Torralba Saban

Research technician
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Marina Hortola Bufi

Marina Hortola Bufi

Research technician
Donation and transplantation of organs, tissues and cells
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.